Note: Ingredients listed on restricted chemical lists
General Information
Revision date
2017-09-03
Product name
Manorapid basic
Emergency telephone
Giftinformationszentrum NORD Universität Göttingen,
Icons in SDS
Company Information
company name
ANTISEPTICA Dr. Hans Joachim Molitor GmbH
e-mail address of the competent person responsible for the Safety Data Sheet
sdb@antiseptica.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H225, H319, H336
Hazard statements
Code
Statements
H225
Highly Flammable liquid and vapour
Section 2
2.1 Classification of the substance or mixture
Regulation (EC) No. 1272/2008
Hazard categories
Flammable liquid: Flam. Liq. 2 Serious eye damage/eye irritation: Eye Irrit. 2 Specific target organ toxicity - single exposure: STOT SE 3
Hazard statements
Highly flammable liquid and vapour. Causes serious eye irritation. May cause drowsiness or dizziness. H225 Highly flammable liquid and vapour. H319 Causes serious eye irritation. H336 May cause drowsiness or dizziness.
2.2 Label elements
Regulation (EC) No. 1272/2008
Hazardous Ingredients
Isopropanol, propan-1-ol; n-propanol In the countries of the EU where the product is registered as a medicinal product, no labeling is carried out according to the CLP regulation (as stated here).
Signal word
Danger
Precautionary statements
P337+P313 If eye irritation persists: Get medical advice/attention. P305+P351+P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P261 Avoid breathing dust/fume/gas/mist/vapours/spray. P235 Keep cool. P233 Keep container tightly closed. P210 Keep away from heat, hot surfaces, sparks, open flames and other ignition sources. No smoking. P102 Keep out of reach of children.
2.3 Other hazards
May form explosive mixtures with air in exceptional situations (for example, misting, development of heat or leakage of large amounts in unventilated spaces). The substances in the mixture do not meet the PBT/vPvB criteria according to REACH, annex XIII.